NEW YORK STOCK EXCHANGE, INC. · Life Sciences Tools & Services · CIK 0001090872
$177.75
+2.74% · delayed ~15 min
Last price from Oct 21, 2026
$50.31B market value
From AGILENT TECHNOLOGIES, INC.'s FY2025 10-K, filed Dec 22, 2025 · read the filing
AGILENT TECHNOLOGIES makes measuring and control instruments. It took in $6.95B last year, which makes it a mid-sized company. Of every dollar it sells, about 19 cents is left as profit.
The financial picture is led by profitability, debt and accounting, with growth worth watching.
A conclusion from the filings, not a recommendation. Detailed figures and supporting evidence appear in their dedicated sections below.
Recent open-market selling by Dolsten Mikael, not under a pre-arranged plan.
$96.0K sold in the last 120 days · Read the filing
These are things the company filed or that a published model flagged — not predictions, and not a reason on their own to buy or sell anything.
Financial health
Strong finances across the board.
From AGILENT TECHNOLOGIES, INC.'s FY2025 annual filing · share price scored separately
Largest year-over-year changes in FY2025
Free cash flow
$1.37B → $1.15B
Cash
$1.33B → $1.79B
Revenue
$6.51B → $6.95B
Gross margin
54.3% → 52.4%
Measured against FY2024, from the 10-K filed Dec 22, 2025
Deteriorated: -16.1%
$1.37B to $1.15BSignificant
Why it matters: Cash left after paying for the plant that produced it — the money genuinely available for dividends, buybacks or paying down debt. Harder to flatter than profit.
How the latest move compares (quote delayed ~15 min), and what was published around it
A rose 2.74% on the latest quote. The average Technology company tracked here moved −1.26%, and the S&P 500 −1.04%. That is 4.0 points above its sector and 3.8 points above the market.
Expectations
Not from the filings — what other people are betting on, and what the price already assumes.
The growth rate someone buying today is paying for, against what the company has delivered
At today's price, the market is paying for free cash flow to grow by about 16% a year for the next 10 years. Over the last 10 years it grew by about 11% a year.
The essentials
Each answered from the filings, with the numbers behind it.
Yes. It keeps about 19 cents of every dollar of sales as profit, earning $1.30B last year.
Slowly. Sales grew 6.7% last year.
No. At its current cash flow it could clear its debt in about 1.0 years. For every $1 it owes, it owns $2.13 in assets.
Core operating and valuation reference metrics
Whether the dividend is covered by what the business actually earns
It pays out 22 cents of every dollar of profit and keeps the rest, which leaves the payment comfortably covered. It paid out 18% of the cash its operations generated. It has paid in each of the last 12 years.
GoodNext payment expected around , projected from how regularly it has paid before rather than from a date the company has announced.
Figures from the FY2025 annual filing
Last year it earned $1.30B and generated $1.56B of cash from operations.
Reported annual figures
As reported to the SEC, in USD. Hover or show sources to see where each figure came from.
| Income statement | FY202510-K · Dec 22, 2025Filing for FY2025 | FY202410-K · Dec 20, 2024Filing for FY2024 | FY202310-K · Dec 20, 2023Filing for FY2023 | FY202210-K · Dec 20, 2023Filing for FY2022 | FY202110-K · Dec 21, 2022Filing for FY2021 | ChangeFY2025 vs FY2024 |
|---|---|---|---|---|---|---|
| RevenueWhat is this? | $6.95B | $6.51B | $6.83B | $6.85B | $6.32B | +6.7% |
| Cost of revenue | $3.31B | $2.98B | $3.37B | $3.13B | $2.91B | +11.1% |
| Gross profit | $3.64B† | $3.54B† | $3.46B† | $3.72B† | $3.41B† | +3.1% |
| Gross marginGross profit ÷ revenueWhat is this? | 52.4% | 54.3% | 50.7% | 54.4% | 53.9% | −1.9 pts |
| Selling, general and administrative | $1.71B | $1.57B | $1.63B | $1.64B | $1.62B | +9.0% |
| Operating income | $1.48B | $1.49B | $1.35B | $1.62B | $1.35B | −0.6% |
| Operating marginOperating income ÷ revenueWhat is this? | 21.3% | 22.9% | 19.8% | 23.6% | 21.3% | −1.6 pts |
| Interest expense | $112.0M | $96.0M | $95.0M | $84.0M | $81.0M | +16.7% |
| Income before tax | $1.44B | $1.52B | $1.34B | $1.50B | $1.36B | −5.7% |
| Net income | $1.30B | $1.29B | $1.24B | $1.25B | $1.21B | +1.1% |
| Net marginNet income ÷ revenueWhat is this? | 18.8% | 19.8% | 18.1% | 18.3% | 19.1% | −1.0 pts |
| Earnings per shareNet income ÷ shares outstanding at the period end — close to, but not the same as, the reported EPSWhat is this? | $4.60 | $4.52 | $4.24 | $4.25 | $4.01 | +1.8% |
† calculated from other reported figures, such as total liabilities as assets minus equity.
This company's latest filing beside its peers' stored scores
| Company | Health | F-Score | Revenue growth | Profit margin | P/E | Debt to equity |
|---|---|---|---|---|---|---|
| AAGILENT TECHNOLOGIES, INC. · this page | 9.0/10 | 6/9 | 6.7% | 18.8% | 38.61x | 0.89x |
Insider activity, ownership stakes and what's coming — straight from EDGAR, before any article is written about it
Officers, directors and major shareholders must report within two business days of a trade.
Was granted or awarded shares — 817 shares at $146.85 ($120.0K)
Holds 817 shares after this filing.
Sold on the open market — 634 shares at $151.38 ($96.0K)
Holds 4,924 shares after this filing.
20 recent filings, newest first. Each is labelled from its form and item numbers, not from its wording.
Had a director or senior officer leave or join · Made a Regulation FD disclosure
Read the filingQuarterly report for Q3 FY2026
Revenue +8.1% · Operating margin +2.9 pts · Gross profit +17.3% — against Q3 FY2025
Read the filingWrite down why you are following AGILENT TECHNOLOGIES, INC., what has to go right and what would change your mind, then see each new annual report measured against it. Sign in to start one.
Go deeper
Every figure above traces back to a filing in the timeline, each linked to the document itself.
Coverage from the last 30 days
DGX Q3 Earnings & Revenues Beat, '26 View Raised, Stock Down in Pre-Market
Yahoo ·
ABT Stock Down Post Q3 Earnings Miss, Revenues Rise Y/Y, Margins Up
Yahoo ·
Bioconjugation Market Report 2026: Global Size, Share, Trends and 2030 Forecast | Capitalize on Targeted Therapeutics | Thermo Fisher, Merck, Danaher, Lonza, and Agilent Lead the Industry
Yahoo ·
Waters Launches AI Link to Advance AI-Enabled LC-MS Workflows
Yahoo ·
Agilent Technologies (NYSE:A) Stands Out as a Quality Stock on Strong Returns and Cash Flow
Every company's figures are checked for internal consistency: the balance sheet adding up, figures sharing one currency, cash flow and share counts within plausible ranges, and how recent the latest annual report is. Nothing here changes a figure.
Financial figures are from A's 10-K for fiscal year 2025 (period ending 2025-10-31, filed Dec 22, 2025), reported under the US GAAP taxonomy. View the source filing.
4 of 4 scored areas had enough reported figures to judge
The score averages profitability, growth, debt and accounting. All four had enough reported figures. Cash generation is shown for context and already feeds profitability. Valuation is scored separately, because a share price says nothing about whether the business is sound. 9 of the 9 Piotroski checks could be evaluated. How the score works
Each year scored only from its annual report as it was first filed
| Fiscal year | Health | F-Score | Scored from |
|---|---|---|---|
| FY2025 | 9.0 | 6/9 | 10-K, filed Dec 22, 2025 |
| FY2024 | 8.0 | 6/9 | 10-K, filed Dec 20, 2024 |
| FY2023 | 8.0 | 6/9 | 10-K, filed Dec 20, 2023 |
| FY2022 | 9.0 | 7/9 | 10-K, filed Dec 21, 2022 |
| FY2021 | 10.0 | 7/9 | 10-K, filed Dec 17, 2021 |
| FY2020 | 9.0 | 6/9 | 10-K, filed Dec 18, 2020 |
A later restatement never reaches back into an earlier year, and every year is scored without a share price, so the latest point can differ a little from the headline score, which uses today's price.
Every check behind the three models, and what each one tests
6 of 9 checks passed
Nine yes-or-no tests of whether this year's finances improved on last year's.
6.34
In the safe zone
For this model, above 2.99 is safe and below 1.81 is distress.
Distance from bankruptcy, from a model fitted on companies that did and did not go bust. It describes a balance sheet's shape today; it does not forecast a failure.
-2.46
Below the threshold — nothing unusual flagged
Scores above -1.78 are the ones the model associates with earnings manipulation.
Screens eight accounting ratios for the pattern earnings manipulators tend to leave. A flag is a reason to read the filing closely, never evidence of wrongdoing.
Every figure above comes from the FY2025 filing as filed with the SEC.
Improved: +34.6%
$1.33B to $1.79BSignificant
Why it matters: A falling cash pile is only a warning if the company is consuming it. Paying down debt, buying back stock and paying a dividend all reduce cash by choice.
Improved: +6.7%
$6.51B to $6.95BNotable
Why it matters: Sales are what everything else is built on. A fall can be lost customers, lower prices, or a business the company sold — the filing itself says which.
Deteriorated: −1.9 pts
54.3% to 52.4%Notable
Why it matters: What survives each sale before overheads. Falling gross margin usually means the company is discounting or its input costs rose — it is the earliest place pricing pressure shows.
Deteriorated: −1.6 pts
22.9% to 21.3%Notable
Why it matters: What survives each sale after running the business. A falling operating margin beside a steady gross margin points at overheads — wages, marketing, research — rather than pricing.
Deteriorated: −1.1 pts
19.8% to 18.8%Notable
Why it matters: What survives to the very end of each sale. Worth reading beside revenue: growing sales on a shrinking margin means the company is buying its growth.
Improved: -8.8%
$3.35B to $3.05BNotable
Why it matters: Rising debt is not automatically bad — borrowing to build something that earns more than the interest is ordinary. It matters when it grows faster than the profit meant to service it.
Changed: +7.7%
$378.0M to $407.0MNotable
Why it matters: Neither good nor bad on its own. Heavy spending is a company building capacity or a company struggling to stand still, and the two look identical in this figure.
Q3 FY2026 against Q3 FY2025, from the 10-Q filed Sep 1, 2026 — read it.
Improved: +17.3%
$888.0M to $1.04BSignificant
Why it matters: What is left of sales after the direct cost of producing them. It normally moves with revenue, so a move out of step with revenue is the part worth noticing.
Improved: +23.3%
$360.0M to $444.0MSignificant
Why it matters: Profit from running the business, before interest and tax. Less exposed than profit to one-off financing and tax items, so a clearer read on the business itself.
Improved: +4.4 pts
51.1% to 55.5%Significant
Why it matters: What survives each sale before overheads. Falling gross margin usually means the company is discounting or its input costs rose — it is the earliest place pricing pressure shows.
Improved: +8.1%
$1.74B to $1.88BNotable
Why it matters: Sales are what everything else is built on. A fall can be lost customers, lower prices, or a business the company sold — the filing itself says which.
Improved: +7.7%
$336.0M to $362.0MNotable
Why it matters: Profit swings far more than sales do, and one-off items — a legal settlement, a tax charge, an asset sale — move it without the underlying business changing.
Improved: +2.9 pts
20.7% to 23.6%Notable
Why it matters: What survives each sale after running the business. A falling operating margin beside a steady gross margin points at overheads — wages, marketing, research — rather than pricing.
Improved: +8.4%
$1.18 to $1.28Notable
Why it matters: Profit divided by the shares in issue at the period end, so it sits close to but not on the company's own reported figure. It can rise with no growth in profit when the company buys back stock — read it beside the share count.
Deteriorated: +8.8%
$3.35B to $3.65BNotable
Why it matters: Rising debt is not automatically bad — borrowing to build something that earns more than the interest is ordinary. It matters when it grows faster than the profit meant to service it.
Improved: +14.5%
$1.53B to $1.76BNotable
Why it matters: A falling cash pile is only a warning if the company is consuming it. Paying down debt, buying back stock and paying a dividend all reduce cash by choice.
Q3 FY2026 against Q2 FY2026, from the 10-Q filed Sep 1, 2026 — read it. Quarter-to-quarter moves include seasonal swings — a retailer's holiday quarter — which the year-earlier comparison removes.
Deteriorated: +19.5%
$3.05B to $3.65BSignificant
Why it matters: Rising debt is not automatically bad — borrowing to build something that earns more than the interest is ordinary. It matters when it grows faster than the profit meant to service it.
Improved: +5.3%
$990.0M to $1.04BNotable
Why it matters: What is left of sales after the direct cost of producing them. It normally moves with revenue, so a move out of step with revenue is the part worth noticing.
Improved: +11.3%
$399.0M to $444.0MNotable
Why it matters: Profit from running the business, before interest and tax. Less exposed than profit to one-off financing and tax items, so a clearer read on the business itself.
Improved: +6.8%
$339.0M to $362.0MNotable
Why it matters: Profit swings far more than sales do, and one-off items — a legal settlement, a tax charge, an asset sale — move it without the underlying business changing.
Improved: +1.5 pts
54.0% to 55.5%Notable
Why it matters: What survives each sale before overheads. Falling gross margin usually means the company is discounting or its input costs rose — it is the earliest place pricing pressure shows.
Improved: +1.9 pts
21.7% to 23.6%Notable
Why it matters: What survives each sale after running the business. A falling operating margin beside a steady gross margin points at overheads — wages, marketing, research — rather than pricing.
Improved: +6.9%
$1.20 to $1.28Notable
Why it matters: Profit divided by the shares in issue at the period end, so it sits close to but not on the company's own reported figure. It can rise with no growth in profit when the company buys back stock — read it beside the share count.
6 other measures barely moved. Figures compare the two most recent annual filings — read the latest one. Moves are graded on fixed lines — 5%, 15% and 40% for amounts, and 1, 3 and 8 points for margins — as notable, significant or critical. Nothing here reads the management commentary, which is where a company explains its own numbers.
These coincide with the move in time. None is presented as its cause: a price can move on news that names no company, on the wider market, or on trading that no document records.
Filter by minute, hour, day or week — or compare against peers
Loading price history…
Discounted at 8%–10% a year, with growth settling to 2.5% after 10 years. Those rates are ordinary choices, not measurements: across that range the assumed growth works out between 14% and 19%. This describes what the price implies — it is not a forecast, and not a view on whether the price is right.
Opinions from 29 analysts covering this company, as of . Their views, not this site's.
Of 29 analysts publishing on this company, 8 say strong buy, 13 say buy and 8 say hold. Analysts are paid to publish a view and are wrong often; the split above says how much they agree with each other, which is the part a single headline rating hides.
Published by Finnhub. Analyst coverage skews towards larger companies and towards optimism — sell ratings are rare across the whole market, so a company with none is ordinary rather than endorsed.
Measured on and published about a week later — this is a fortnightly snapshot, not a live position.
About 1.9% of this company's shares have been borrowed and sold by people expecting to buy them back cheaper. That is a bet the price falls. Those people can be wrong, and when a heavily shorted share rises they have to buy it back, which pushes it up further.
Collected by FINRA from broker-dealers twice a month. It counts positions, not intentions, and some of it is hedging rather than a directional bet against the company.
Nothing in this section is a figure this company reported about itself. These are expectations and positions — what the price implies, what analysts have published, what short sellers are betting, and what large funds held at the last count. WylthIQ reports them; it does not endorse them, does not forecast prices, and takes no view on whether any of them will turn out to be right.
The trailing P/E is 37.5x — a high multiple relative to the current trailing profit.
Nothing unusual. Its accounting patterns look like those of companies that report earnings straightforwardly.
| 7.3/10 |
| 6/8 |
| 3.9% |
| 15.0% |
| 38.07x |
| 1.07x |
| DHRDANAHER CORP /DE/ | 9.0/10 | 5/9 | 2.9% | 14.7% | 44.94x | 0.59x |
|---|
| IQVIQVIA HOLDINGS INC. | 6.0/10 | 5/9 | 5.9% | 8.3% | 34.71x | 3.59x |
|---|
| WATWATERS CORP /DE/ | 9.0/10 | 6/9 | 7.0% | 20.3% | 42.22x | 0.98x |
|---|
| MTDMETTLER TOLEDO INTERNATIONAL INC/ | 8.7/10 | 7/9 | 4.0% | 21.6% | 39.46x | -158.08x |
|---|
| Median of peers | 8.7/10 | — | 4.0% | 15.0% | 39.46x | 0.98x |
|---|
Peers come from the company's industry classification. A difference describes the companies; it does not rank them.
Had shares withheld to cover taxes — 30 shares at $136.01 ($4.1K)
Holds 14,108 shares after this filing.
Notice filed ahead of a planned sale — the sale itself has not necessarily happened yet.
Filed notice to sell 634 shares ($96.0K) on or after .
Shares originally obtained via Restricted Stock Vesting.
Estimated from how often this has happened before, not a confirmed date.
Not investment advice, and not a signal to act on by itself — a filing says what happened, not why, and insiders trade for ordinary reasons having nothing to do with where they think the company is headed.
Published results
Signed a material agreement · Took on a direct financial obligation
Read the filingQuarterly report for Q2 FY2026
Revenue +10.0% · Operating margin +3.8 pts · Profit +57.7% — against Q2 FY2025
Read the filingHad a director or senior officer leave or join · Published results
Read the filingHad a director or senior officer leave or join · Made a Regulation FD disclosure
Read the filingHad a director or senior officer leave or join
Read the filingChanged control of the company
Read the filingAmended its charter or changed its financial year · Held a shareholder vote
Read the filingHad a director or senior officer leave or join
Read the filingQuarterly report for Q1 FY2026
Revenue +7.0% · Operating margin −2.7 pts · Free cash flow -47.6% — against Q1 FY2025
Read the filingPublished results
Read the filingProxy statement for a shareholder meeting
Read the filingAnnual report for FY2025
Revenue +6.7% · Operating margin −1.6 pts · Free cash flow -16.1% — against FY2024
Read the filingPublished results
Read the filingHad a director or senior officer leave or join
Read the filingQuarterly report for Q3 FY2025
Revenue +10.1% · Profit margin +1.5 pts · Long-term debt +56.8% — against Q3 FY2024
Read the filingPublished results
Read the filingHad a director or senior officer leave or join
Read the filingChartMill ·
Primary sources and further research